This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 May 1;195(9):1274-1275.

doi: 10.1164/rccm.201610-2033LE.

Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

Tomoyuki Kawada¹

Affiliations

PMID: 28459342
DOI: 10.1164/rccm.201610-2033LE

Comment

Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

Tomoyuki Kawada. Am J Respir Crit Care Med. 2017.

. 2017 May 1;195(9):1274-1275.

doi: 10.1164/rccm.201610-2033LE.

Author

Tomoyuki Kawada¹

Affiliation

¹ 1 Nippon Medical School Tokyo, Japan.

PMID: 28459342
DOI: 10.1164/rccm.201610-2033LE

No abstract available

PubMed Disclaimer

Comment in

Reply: Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
Costabel U, Stansen W, Stowasser S. Costabel U, et al. Am J Respir Crit Care Med. 2017 May 1;195(9):1275. doi: 10.1164/rccm.201610-2155LE. Am J Respir Crit Care Med. 2017. PMID: 28459331 No abstract available.

Comment on

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Costabel U, Inoue Y, Richeldi L, Collard HR, Tschoepe I, Stowasser S, Azuma A. Costabel U, et al. Am J Respir Crit Care Med. 2016 Jan 15;193(2):178-85. doi: 10.1164/rccm.201503-0562OC. Am J Respir Crit Care Med. 2016. PMID: 26393389 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations